Drug-eluting stents for off-label indications in real clinical world: Evidence based or 'intuition' based clinical practice?

International Journal of Cardiology

Volumn 164, Issue 1, 2013, Pages 116-122

  Ribera, Aida ^a,b   Ferreira González, Ignacio ^a,b   Del Blanco, Bruno García ^a   Marsal, Josep R ^a,b   Cascant, Purificación ^a,b   Martí, Gerard ^a   Cequier, Ángel R ^c   Gómez Hospital, Joan Antoni ^c   Fernandez Nofrerías, Eduard ^d   Carrillo, Xavier ^d   López Pérez, M Carmen ^e   Navarro, Josep ^f   Raso, Rafael ^f   García Dorado, David ^a   Permanyer Miralda, Gaietà ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e Hospital Sagrada Familia   (Spain)

^f HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Drug eluting stents; Multilevel logistic regression; Off label indications

Indexed keywords

AGE; AGED; ARTICLE; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DRUG ELUTING STENT; FEMALE; FUNDING; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; OFF LABEL INDICATION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PRIVATE HOSPITAL; PUBLIC HOSPITAL; REPEAT PROCEDURE; SPAIN; TEACHING HOSPITAL; TREATMENT INDICATION; ADULT; BARE METAL STENT; CLINICAL PRACTICE; CONTROLLED STUDY; EVIDENCE BASED PRACTICE; HEALTH CARE AVAILABILITY; INTUITION BASED CLINICAL PRACTICE; MIDDLE AGED; REVASCULARIZATION;

AGED; DRUG-ELUTING STENTS; EVIDENCE-BASED MEDICINE; FEMALE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; REGRESSION ANALYSIS;

EID: 84875213196     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.06.096     Document Type: Article

References (26)

1. E. Grube, S. Silver, and K.E. Hauptmann TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions Circulation 107 2003 38 42
2. A. Colombo, J. Drzewiecki, and A. Banning Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions Circulation 108 2003 788 794
3. G.W. Stone, J.W. Moses, and S.G. Ellis Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents N Engl J Med 356 2007 998 1008
4. S.J. Park, W.H. Shim, and D.S. Ho A paclitaxel-eluting stent for the prevention of coronary restenosis N Engl J Med 348 2003 1537 1545
5. A. Gershlick, S.I. De, and B. Chevalier Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial Circulation 109 2004 487 493
6. G.W. Stone, S.G. Ellis, and D.A. Cox One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial Circulation 109 2004 1942 1947
7. A.J. Lansky, R.A. Costa, and G.S. Mintz Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial Circulation 109 2004 1948 1954
8. M.C. Morice, P.W. Serruys, and J.E. Sousa A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 2002 1773 1780
9. J.W. Moses, M.B. Leon, and J.J. Popma Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
10. N. Beohar, C.J. Davidson, and K.E. Kip Outcomes and complications associated with off-label and untested use of drug-eluting stents JAMA 297 2007 1992 2000
11. O.C. Marroquin, F. Selzer, and S.R. Mulukutla A comparison of bare-metal and drug-eluting stents for off-label indications N Engl J Med 358 2008 342 352
12. A. Farb, and A.B. Boam Stent thrombosis redux - the FDA perspective N Engl J Med 356 2007 984 987
13. S.V. Rao, R.E. Shaw, and R.G. Brindis Patterns and outcomes of drug-eluting coronary stent use in clinical practice Am Heart J 152 2006 321 326
14. H.K. Win, A.E. Caldera, and K. Maresh Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents JAMA 297 2007 2001 2009
15. D.J. Malenka, A.V. Kaplan, F.L. Lucas, S.M. Sharp, and J.S. Skinner Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents JAMA 299 2008 2868 2876
16. B.R. Brodie, T. Stuckey, and W. Downey Outcomes and complications with off-label use of drug-eluting stents: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) group JACC Cardiovasc Interv 1 2008 405 414
17. M.T. Roe, A.Y. Chen, and C.P. Cannon Temporal changes in the use of drug-eluting stents for patients with non ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention from 2006 to 2008: results from the Can Rapid risk stratification of Unstable angina patients Supress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE) and Acute Coronary Treatment and Intervention Outcomes Network Get with The Guidelines (ACTION GWTG) Registries Circ Cardiovasc Qual Outcomes 2 2009 414 420
18. S.K. Gualano, H.S. Gurum, and D. Share Temporal trends in the use of drug-eluting stents for approved and off-label indications: a longitudinal analysis of a large multicenter percutaneous coronary intervention registry Clin Cardiol 33 2010 111 116
19. P. Wenaweser, J. Daemen, and M. Zwahlen Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study J Am Coll Cardiol 52 2008 1134 1140
20. M. Pfisterer, H.P. Brunner-La Rocca, and P.T. Buser Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents J Am Coll Cardiol 48 2006 2584 2591
21. M. Shuchman Debating the risks of drug-eluting stents N Engl J Med 356 2007 325 328
22. W.H. Maisel Unanswered questions - drug-eluting stents and the risk of late thrombosis N Engl J Med 356 2007 981 984
23. J. Merlo, B. Chaix, and H. Ohlsson A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena J Epidemiol Community Health 60 2006 290 297
24. I. Ferreira-González, J.R. Marsal, and A. Ribera Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation Circulation 122 2010 1017 1025
25. C.L. Bryce, and K.E. Cline The supply and use of selected medical technologies Health Aff(Millwood.) 17 1998 213 224
26. K. Larsen, J.H. Petersen, E. Budtz-Jorgensen, and L. Endahl Interpreting parameters in the logistic regression model with random effects Biometrics 56 2000 909 914